12th Jan 2026 15:45
Fortis Frontier PLC
("Fortis Frontier" or the "Company")
Transaction in Own Shares and Total Voting Rights
Fortis Frontier plc (AIM: FORF), an AIM Rule 15 cash shell (formerly MyHealthChecked PLC), announces that on 9 January 2026, pursuant to the authority approved by shareholders at the Company's Annual General Meeting of 31 July 2025, the Company purchased 100,000 ordinary shares of 1.5 pence each ("Ordinary Shares") for cancellation at a price of 8 pence per share.
In addition, 105 Ordinary Shares held in treasury since the share consolidation in May 2023 will also be cancelled.
Summary of Trades
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 (which forms part of domestic law pursuant to the European Union (Withdrawal) Act 2018), details of the purchase of its own ordinary shares by Fortis Frontier plc which were all executed through the Company's broker, Dowgate Capital, are set out below:
Date of Purchase | 9 January 2026 |
Number of ordinary shares purchased/aggregated volume | 100,000 |
Highest price paid per ordinary share | 8p |
Lowest price paid per ordinary shares | 8p |
Volume weighted average price paid per ordinary shares | 8p |
Trading Venue | London Stock Exchange |
Total Voting Rights
An application to cancel the repurchased shares will be made as soon as practicable, pending which the shares will be held in treasury. Following settlement of the above purchases and cancellation of the Ordinary Shares held in treasury, the Company's total number of ordinary shares in issue shall be 51,935,827.
The total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information contact:
Fortis Frontier PLC | www.fortisfrontierplc-ir.com | ||
Adam Reynolds, Executive Chairman | via Walbrook PR | ||
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | ||
Neil Baldwin / Dillon Wall | |||
Dowgate Capital Limited (Broker) | Tel: +44 (0)20 3903 7715 | ||
David Poutney / Russell Cook | |||
Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or Fortis [email protected] | ||
Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44(0)7407 804 654 | ||
About Fortis Frontier PLC
On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 Cash Shell, as defined in the AIM Rules for Companies. On the same day the Company changed its name to Fortis Frontier PLC. The Board is now carefully considering the strategic options available to it in order to maximise shareholder value.
Related Shares:
Fortis Frontier